期刊文献+

磁珠分离DNA技术检测HIV-1逆转录酶基因耐药性突变 被引量:1

Detection of Drug-resistant Mutations in HIV-1 RT Gene Using Magnetic Beads Associated DNA Isolation Technology
下载PDF
导出
摘要 HIV-1逆转录酶基因突变导致的耐药性严重影响了药物对病人的治疗效果,耐药性突变的检测对于指导合理用药具有重要意义。发展了一种检测HIV-1逆转录酶基因耐药性突变的新方法,在两步MS-PCR方法的基础上,引入磁珠分离DNA技术并结合酶联免疫吸附检测方法(ELISA)检测逆转录酶基因耐药性突变T215F和Y181C。结果显示:MS-PCR结合磁珠分离技术和ELISA具有较高的灵敏度和特异性,阳性/阴性比值(P/N值)达到要求,突变型模板检测限为5%左右,耗时短且能进行高通量检测。无论在HIV-1耐药性突变还是其它的点突变检测中,该方法都具有较好的临床应用前景。 In recent years, the emergence of drug-resistant RT gene mutations in HIV-1 strains has become the major reason for AIDS treatment failure. The detection of drug-resistant mutations is important for the treatment choice. A novel assay for the detection of HIV-1 RT drug-resistant mutations was developed. Drugresistant and wild strains of HIV-1 B subtype were investigated based on Two-Step MS-PCR. Magnetic beads associated DNA isolation technology and ELISA were employed in this assay to detect point mutations including Y181C and T215F. As a result, this novel assay gave a good P/N ratio and as less as about 5% of mutant type template could be detected, indicating that this assay is highly sensitive and specific. The assay can be completed in relatively less time consumption and applied in high-throughput screening. The method has great potential for using in clinic assay for the detection of HIV-1 drug-resistant mutations as well as other point mutations.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2008年第8期105-109,共5页 China Biotechnology
基金 国家自然科学基金(30500429,30670497) 北京市自然科学基金(5072002) 北京市教委基金面上项目(KM200510005001)资助项目
关键词 逆转录酶 耐药性突变 磁珠 ELISA MS-PCR Reverse transcriptase Drug-resistant mutation Magnetic beads ELISA MS-PCR
  • 相关文献

参考文献13

  • 1BHIVA Writing Committee on behalf of the BHIVA Executive Committee. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Medicine, 2000, 1: 76- 101
  • 2司雪峰,黄海龙,魏民,关琪,宋艳辉,马鹏飞,全宇,邢辉,邵一鸣.我国HIV-1感染者耐药突变的流行性研究[J].中华实验和临床病毒学杂志,2004,18(4):308-311. 被引量:45
  • 3Gallant J E, Gerondelis P Z, Wainberg M A, et al. Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistance. Antivir Ther, 2003, 8 (6) : 489 -506
  • 4Gingolani A, Antinori A, Rizzo M G, et al. Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA). AIDS, 2002, 16 (3) : 369-379
  • 5吴守丽,严延生,蒋岩.HIV耐药性检测方法及其临床应用[J].中国艾滋病性病,2004,10(4):312-315. 被引量:5
  • 6Frater A J, Chaput C C, Beddows S, et al. Simple detection of point mutations associated with HIV-1 drug resistance. Journal of Virological Methods. 2001,93 ( 1 ) : 145-156
  • 7Vahey M, Nau M E, Barrick S, et al. Performance of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates with length polymorphisms. J Clin Microbiol, 1999, 37 (8) : 2533-2537
  • 8Myint L, Ariyoshi K, Yan H, et al. Mutagenically separated PCR assay for rapid detection of M41L and KTOR zidovudine resistance mutations in CRF01 AE (Subtype E ) human immunodeficiency virus type 1. Antimicrob Agents Chemother, 2002, 46 (12) : 3861-3868
  • 9Rust S, Funke H, Assmann G. Mutagenically separated PCR (MS-PCR): a highly specific one step procedure for easy mutation detection. Nucleic Acids Res, 1993, 21 (16) : 3623-3629
  • 10Chang J G, Lu J M, Huang J M, et al. Rapid diagnosis of beta-thalassaemia by mutagenically separated polymerase chain reaction (MS-PCR) and its application to prenatal diagnosis. Br J Haematol, 1995, 91 (3) : 602-607

二级参考文献41

  • 1司雪峰,黄海龙,魏民,关琪,宋艳辉,马鹏飞,全宇,邢辉,邵一鸣.我国HIV-1感染者耐药突变的流行性研究[J].中华实验和临床病毒学杂志,2004,18(4):308-311. 被引量:45
  • 2Martínez M A,Cabana M,Parera M,et al. A bacteriophage lambda-based genetic screen for characterization of the activity and phenotype of the human immunodeficiency virus type 1 protease[J]. Antimicrobial Agents and Chemotherapy,2000,44:1132-1139.
  • 3Iga M,Matsuda Z,Okayama A,et al. In vitro human immunodeficiency virus type 1protease phenotypic assay using in vitro transcription translation system[C]. In First HIV DRP Symposium Understanding Antiviral Drug Resistance,Chantilly,VA. USA. 2000,40.
  • 4Graham N,Peeters M,Verbiest W,et al. The virtual phenotype is an independent predictor of clinical response[C]. Program and abstracts of the 8th Conferenec on Retroviruses and Opportunistic Infections, Chicago,I11inois. 2001,524.
  • 5Larder BA,Kemp S,Hertogs K. Quantitative prediction of HIV-1 phenotypic drug resistance from genotypes:the virtual phenotype[C]. Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy,Toronto,Ontario,Canada. 200
  • 6Hirsch M S,Brun-Vézinet F,D'Aquila R T,et al. Antiretroviral drug resistance testing in adult HIV-1 infection:recommendations of an international AIDSsociety-USA panel[J]. Journal of the American Medical Association,2000,283:2417-2426.
  • 7Stuyver L,Wyseur A,Rombout A,et al. line probe assay for rapid detection of drug-selected mutationsin the human immunodeficiency virus type 1 reverse transcriptase gene [J]. Antimicrob Agents Chemother,1997,41:284-291.
  • 8Edelstein RE, Nickerson DA, Tobe VO. Oligonucleotide Ligation Assay for Detecting Mutations in the Human Immunodeficiency Virus Type 1 pol Gene That Are Associated with Resistance to Zidovudine,Didanosine,and Lamivudine [J]. Journal of Clinical Microbiolo
  • 9Gunthard HF,Wong JK,Ignacio CC,et al. Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIVtype 1 pol from clinical samples[J]. AIDS Res Hum Retroviruses,1998,14:869-876.
  • 10Kozal MJ,Yahi N,Ariasi F,et al. Comparison of Human immunodeficiency virus type 1 protease mutations in HIV-1 genomes detected in plasma and in peripheral blood mononuclear cells from patients receiving combination drug therapy[J]. J Clin Microbiol,1993,3

共引文献49

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部